To study Phase I trial of EOS 100850 for safety and efficacy.

Trial Profile

To study Phase I trial of EOS 100850 for safety and efficacy.

Not stated
Phase of Trial: Phase I

Latest Information Update: 14 Feb 2018

At a glance

  • Drugs EOS-100850 (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Feb 2018 New trial record
    • 09 Feb 2018 According to iTeos Therapeutics media release, trial expected to begin in 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top